ADMINISTRATION SITE FIBROSIS

ADMINISTRATION SITE FIBROSIS was reported 4 times

ADMINISTRATION SITE FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin [EPC] 1 0.0000
1 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
2 Cardiac Glycoside [EPC] 1 0.0000
3 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
4 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
5 Prostacycline Vasodilator [EPC] 1 0.0000
6 Aldosterone Antagonist [EPC] 1 0.0000
7 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
8 Endothelin Receptor Antagonist [EPC] 1 0.0000
9 RANK Ligand Inhibitor [EPC] 1 0.0000
10 Factor Xa Inhibitor [EPC] 1 0.0000
11 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
12 Insulin Analog [EPC] 1 0.0000
13 Loop Diuretic [EPC] 1 0.0000
14 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
15 Corticosteroid [EPC] 1 0.0000